NIH’s 2017 Monitoring the Future survey shows both vaping and marijuana are more popular than traditional cigarettes or pain reliever misuse. Read More
ombination allows more than 80 percent of children to safely consume at least two foods to which they were allergic. Read More
Effort streamlines study infrastructure to improve recruitment diversity, advance research. Read More
The numbers will more than double to 15 million by 2060. Read More
Vaccine developed by NIH scientists shows promise in Phase 1 testing. Read More
Results support further clinical development. Read More
After 30 years of marking progress against HIV, we are closer than ever to the beginning of the end of the HIV/AIDS pandemic. Read More
Over 90 percent of homes had three or more detectable allergens. Read More
Public-private partnership begins clinical trial in sub-Saharan Africa. Read More
Study to test efficacy, safety of injectable cabotegravir compared with daily oral PrEP. Read More
